Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

10.34
Delayed Data
As of Sep 18
 -0.02 / -0.19%
Today’s Change
4.55
Today|||52-Week Range
15.82
-30.60%
Year-to-Date
Implied Volatility Surging for Eiger BioPharmaceuticals (EIGR) Stock Options
Sep 15 / Zacks.com - Paid Partner Content
Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
Aug 22 / Seeking Alpha - Paid Partner Content
Enanta Pharma reports encouraging data on HBV and NASH candidates
Aug 28 / Seeking Alpha - Paid Partner Content
Seeking Alpha Catalyst Watch
Aug 21 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close10.36
Today’s open10.45
Day’s range10.14 - 10.52
Volume10,407
Average volume (3 months)429,846
Market cap$293.6M
Data as of 4:00pm ET, 09/18/2020

Growth & Valuation

Earnings growth (last year)+19.31%
Earnings growth (this year)+71.24%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
UROVUrovant Sciences Ltd+0.38+3.91%
VYNEVyne Therapeutics In...+0.03+1.66%
AQSTAquestive Therapeuti...+0.12+1.35%
PRTKParatek Pharmaceutic...+0.15+2.30%
Data as of 4:27pm ET, 09/18/2020

Financials

Next reporting dateNovember 5, 2020
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$0.00
Annual profit (last year)-$70.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Palo Alto, California

Forecasts